Equity of the Meningitis B vaccination programme in England, 2016-2018
<p>In England, the Meningitis B (MenB) vaccine is scheduled at eight and 16 weeks with a booster dose at one year of age and protects children against invasive bacterial meningococcal disease caused by <em>Neisseria meningitidis</em> serogroup B. Coverage...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2022
|